Abstract
Stroke prevention is highly effective but underutilized in medical care. Lifestyle modification, in the form of diet, exercise, smoking cessation, antihypertensive therapy, close control of diabetes and hyperlipidemia, can prevent most strokes. Selected subgroups can benefit from carotid surgery or stenting, anticoagulation for atrial fibrillation, and antiplatelet therapy. Evidence for these approaches and alternative management strategies are discussed.
Keywords: Ischemic stroke, secondary stroke prevention, antiplatelet therapy
Current Pharmaceutical Design
Title:Antiplatelet and Anticoagulation Strategies in the Prevention and Treatment of Ischemic Stroke
Volume: 18 Issue: 33
Author(s): Howard S. Kirshner
Affiliation:
Keywords: Ischemic stroke, secondary stroke prevention, antiplatelet therapy
Abstract: Stroke prevention is highly effective but underutilized in medical care. Lifestyle modification, in the form of diet, exercise, smoking cessation, antihypertensive therapy, close control of diabetes and hyperlipidemia, can prevent most strokes. Selected subgroups can benefit from carotid surgery or stenting, anticoagulation for atrial fibrillation, and antiplatelet therapy. Evidence for these approaches and alternative management strategies are discussed.
Export Options
About this article
Cite this article as:
S. Kirshner Howard, Antiplatelet and Anticoagulation Strategies in the Prevention and Treatment of Ischemic Stroke, Current Pharmaceutical Design 2012; 18 (33) . https://dx.doi.org/10.2174/138161212803251961
DOI https://dx.doi.org/10.2174/138161212803251961 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
HIV-1 Infection In Children: A Clinical and Immunologic Overview
Current HIV Research Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
Current Diabetes Reviews Molecule of the Month
Current Topics in Medicinal Chemistry Biomarkers of Atrial Fibrillation in Hypertension
Current Medicinal Chemistry Key miRNAs in Modulating Aging and Longevity: A Focus on Signaling Pathways and Cellular Targets
Current Molecular Pharmacology A Brief History of ‘Lone’ Atrial Fibrillation: From ‘A Peculiar Pulse Irregularity’ to a Modern Public Health Concern
Current Pharmaceutical Design Amniotic Fluid Embolism: Moving Diagnosis Through the Time. From the Mechanical Pulmonary Vascular Occlusion Until An Immuno - Inflammatory Pathogenesis?
Current Pharmaceutical Biotechnology Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design Meet Our Editorial Board Member:
Current Diabetes Reviews Metabolic Syndrome and Myocardial Infarction in Women
Current Pharmaceutical Design Mst1: Function and Mechanism in Brain and Myocardial Ischemia Reperfusion Injury
Current Neuropharmacology Tissue Doppler Imaging in Coronary Artery Diseases and Heart Failure
Current Cardiology Reviews Current Developments on Synthesis, Redox Reactions and Biochemical Studies of Selenium Antioxidants
Current Chemical Biology Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Relationship of High-Sensitivity C-Reactive Protein Concentrations and Systolic Heart Failure
Current Vascular Pharmacology Xanthine Oxidase Inhibitors the Unappreciated Treatment for Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Patent Annotations
Recent Patents on Cardiovascular Drug Discovery Pediatric Heart Failure in the Developing World
Reviews on Recent Clinical Trials Prediction of MicroRNA–disease Associations by Matrix Completion
Current Proteomics Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications
Current Drug Targets